MedPath

The Diagnosis and Treatment System of Transesophageal Echocardiography in ICU

Not Applicable
Conditions
Critically Ill
Registration Number
NCT03811730
Lead Sponsor
Kang Yan
Brief Summary

Transesophageal ultrasound offers imaging through the esophagus on the surface of the heart, with good image quality and unique advantages. However, no studies to date have examined its effect in critically ill patients in China.Therefore, the investigators aimed to compare the efficacy and safety of TEE with TTE. the investigators will conducte a Multi-center, prospective observational control study enrolling critically ill adult patients in several ICU in China .

Detailed Description

Patients in ICU were assessed for the need for TEE by trained researcher. Eligible patients would be conducted tee examination by researcher A, TTE by the researcher B ,at the same time, researcher C records the basic condition and clinical data of patientsand carried out micro-enlargement test.The examination results are judged by A and B respectively and provided to the physician of this patient, and A return visit to the physician wold be conducted by researcher D to evaluate the acceptance of TTE and TEE results and judge the clinical effects. The primary outcome is the clinical effects.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. The quality of Transthoracic echocardiography is poor ( >3 sections cannot be obtained or the inner membrane is not clear)
  2. The diagnosis of the etiology by Transthoracic ultrasonography is still unclear
  3. The results of Transthoracic ultrasonography are inconsistent with clinical judgment or cannot explain the existing signs.
  4. No obvious improvement or even aggravation after thoracic examination and corresponding treatment
  5. Special conditions or clinical scenarios
  6. Other clinicians think a TEE check is required.
Exclusion Criteria
  1. There is a tee test taboo and clinicians evaluate the risk over benefit
  2. Did not sign an informed consent form

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Conclusion of the adoption48 hours after completion of the examination

Researcher C conducted a questionnaire survey on attending physician to evaluate the effect

Secondary Outcome Measures
NameTimeMethod
adverse eventscompletion of the examination

Adverse events associated with the examination,eg.1.Anesthetic allergy;2.Nausea, vomiting, choking cough or aspiration;3.Laryngeal edema and even asphyxiation;4.Severe arrhythmia;5.Esophageal perforation, bleeding, or local hematoma;6.Other accidental deaths, such as acute myocardial infarction, shock, haemorrhage and possibly even death;7.Other unpredictable contingencies or complications

Trial Locations

Locations (5)

Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences

🇨🇳

Beijing, China

Xiangya Hospital Central South University

🇨🇳

Changsha, China

The People's Hospital of Guangxi Zhuang Autonomous Region

🇨🇳

Nanning, China

The First Hospital of China Medical University

🇨🇳

Shengyang, China

Zhongnan Hospital of Wuhan University

🇨🇳

Wuhan, China

Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences
🇨🇳Beijing, China
Hua Zhao
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.